UNSPSC 85552310: Supplement right retina with nonautologous tissue substitute, open approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement right retina with nonautologous tissue substitute, open approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 08UE0KZ

UNSPSC 85552310 Supplement right retina with nonautologous tissue substitute, open approach is a Commodity code that does not align with recent state and local procurement activity. The code's technical medical-surgical scope—ophthalmic tissue grafting—does not match the healthcare services and staffing work actually being solicited by state and local jurisdictions under this classification.

Recent opportunities tagged to this code span occupational medical surveillance, independent medical evaluations for pension disability determinations, surgical benefit carve-out network management, pharmacy benefit management, and temporary health professional staffing—none of which involve retinal surgery or tissue substitution. The Washington State Department of Transportation (RFP20260825, due October 9, 2026) seeks occupational medical surveillance services for ferry system workers across 14 Washington locations; the City of Phoenix Retirement Office (RTMRFP26001, due October 16, 2026) requests independent medical evaluation services for public safety pension disability applications with a $750,000 maximum over five years; the City of Long Beach (HR26753, due October 7, 2026) solicits a surgical and medical procedure carve-out benefit program for Centers of Excellence networks; and the County of Santa Clara Health System (RFSQHHSFY270052, due October 7, 2026) is establishing a qualified vendor pool for temporary ancillary health professional staffing. These represent administrative healthcare services and staffing, not surgical interventions. The code shows little relevant recent activity for firms pursuing surgical implants, tissue substitutes, or ophthalmologic devices.